The FDA's REMS for Psychedelics

The FDA sets up rules for how you can administer a drug, and the most common example is opiates. We really need to talk about disease-specific REMS and substance- Specific Risk Mitigation Strategy (RMS) If they make these REMS, this is what it is for all psychedelics, regardless of what you're treating it for, then it's going to be a real problem. I don't think we've seen this done this way before at the US level. How do we make multimodal accessibility a reality? Yes, prescriptions, yes, home grow, yes, community, gift and growing, all that. But how do we get there? It's going

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.